Nanogen, Inc., developer of advanced diagnostic products, announced today that it has been granted United States Patent No. 7,252,940, titled "Abasic site endonuclease assay" from the U.S. Patent and Trademark Office.
NeoPhotonics announced today a new line of pluggable GPON transceivers, compliant with the ITU-T G.984.2 Class B+ standard, to augment its portfolio of Biplexer and Triplexer modules used in "fiber to the premises" (FTTP) networks around the world.
Nano-Proprietary, Inc. today announced that upon successful conclusion of its initial research project with a leading industrial chemical products company in Japan, its subsidiary, Applied Nanotech, Inc., has entered into an extension of its research and development partnership agreement to develop technical inks.
Carl Zeiss SMT today announced that Harvard University's Faculty for Arts and Sciences (FAS) has selected a number of its most advanced instruments for use at the FAS Center for Nanoscale Systems (CNS).
GE Global Research and GE Healthcare today announced a three-year collaborative research agreement with Eli Lilly and Company to discover and develop advanced in vitro diagnostic assays that may predict cancer treatment response to targeted therapies.
NaturalNano, Inc., a developer of advanced nanocomposite materials and additive technologies, today announced that it has hired Lambert, Edwards & Associates, Inc. to direct the Company's investor relations activities.